Product Title: The New Abnormal: The Rise of the Biomedical Security State (EPUB)
Format:
EPUB, 5.7 MB
Overview (Details, Topics and Speakers):
By Aaron Kheriaty
The coronavirus pandemic conferred enormous power on certain government officials. They have no intention of giving it up.In the space of a few weeks in early 2020, Americans witnessed the imposition of previously unimagined social controls by the biomedical security state—the unelected technocrats who suddenly enjoyed nearly absolute power to incarcerate, isolate, and medicate the entire population. In this chilling new book, a dissident scientist reveals
- the people and organizations that form the biomedical security state
- its role in the origin of the pandemic and shaping the government response
- why it is a threat to science, public health, and individual freedom
- what can be done to confront and defeat this new Leviathan
When covid-19 broke out, Dr. Aaron Kheriaty’s work put him on the front lines. Realizing that the mental, physical, and economic toll of lockdowns was catastrophic, he began to protest that the cure was worse than the disease—an intolerable heresy. When he refused vaccination because he had natural immunity from a previous infection, the University of California, Irvine, medical school fired him. He fought back, in the courts and in the media, and has become a reliable source of truth amid official obfuscation and censorship. Now it’s time for all of us to fight back. The deadly and arrogant misrule of the biomedical security state must not become the “new normal.”
Product Details
- Publisher : Regnery Publishing (November 1, 2022)
- Language : English
- Hardcover : 256 pages
- ISBN-10 : 1684513855
- ISBN-13 : 978-1684513857
Delivery Method
the The New Abnormal: The Rise of the Biomedical Security State (EPUB) course/book will be provided for customer as download link. download link has NO Expiry and can be used anytime.
Contact Us
contact us to our email at support@med-cme.com or fill in the form below:
Reviews
There are no reviews yet.